Rejoint, an innovative Bologna-based startup specializing in customized knee prosthetics, raised €1.35 million from IAG business angels and Doorway community investors to enhance its market presence and refine its technology.
Target Information
Rejoint is an innovative startup based in Bologna, Italy, specializing in the development of customized knee prosthetics. Recently, the company successfully secured a €1.35 million investment round from the business angels of IAG and community investors via the online equity investment platform, Doorway. Rejoint addresses a critical issue in orthopedic medicine, where over 20% of patients undergoing knee prosthetic surgeries express dissatisfaction due to various complications that impact their quality of life, such as pain, inflammation, and size mismatches.
The technological solutions offered by Rejoint are disruptive. Their approach employs augmented reality, artificial intelligence, advanced 3D printing technology, and big data integration through sensor-enabled braces to enhance patient monitoring and improve rehabilitation outcomes. This personalized device design is aimed at significantly improving patient experiences in knee surgery.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview of Orthopedics in Italy
The orthopedic industry in Italy is mature and continuously evolving, driven by advancements in technology and an increasing aging population that demands better healthcare services. With a focus on personalized medical solutions, healthcare providers are under pressure to impro
Similar Deals
CDP Venture Capital → Arsenale Bioyards
2025
Utopia SIS and Pariter Partners → LighthouseBiotech
2023
Italian Angels for Growth, Club degli Investitori, Doorway → AorticLab
2023
IAG and Doorway
invested in
Rejoint
in 2023
in a Seed Stage deal
Disclosed details
Transaction Size: $1,350M